By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Asceneuron 

EPFL Innovation Park
Bâtiment B
Lausanne    CH-1015  Switzerland
Phone: n/a Fax: n/a


SEARCH JOBS

Asceneuron was founded in 2012 through a spin-off of Merck Serono’s Alzheimer’s drug discovery portfolio and research group in Switzerland. We are a privately held company financed by a strong syndicate of investors consisting of Sofinnova Partners, SR One, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Kurma Partners and Merck Ventures.

YEAR FOUNDED:

2012

LEADERSHIP:

CEO: Dirk Beher

COO: Christoph Wiessner

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email:
Ownership: Private

Web Site: Asceneuron
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->